nation
taiwan
univers
hospit
ntuh
adopt
intern
guidelin
surveil
control
healthcareassoci
infect
hcai
report
describ
secular
trend
hcai
ntuh
past
year
accord
site
infect
aetiolog
agent
control
measur
clinic
microbiolog
data
collect
infect
prevent
control
nurs
use
standardis
caserecord
form
specif
control
programm
implement
andor
intensifi
need
poisson
neg
binomi
regress
analysi
use
quantifi
time
trend
incid
hcai
annual
number
discharg
increas
parallel
increas
charlson
comorbid
index
activ
hcai
surveil
period
feedback
associ
mark
decreas
surgic
site
infect
vs
episod
per
procedur
p
hand
increas
bloodstream
infect
bsi
vs
episod
per
discharg
p
averag
annual
increas
pathogenspecif
hcai
incid
meticillinresist
staphylococcu
aureu
mrsa
extens
drugresist
baumannii
xdrab
candida
albican
p
respect
infect
prevent
control
programm
upgrad
implement
annual
intens
projectbas
control
programm
decreas
rate
hcai
bsi
mrsa
xdrab
observ
long
term
studi
demonstr
need
coupl
surveil
hcai
focus
control
programm
hospit
must
invest
adequ
manpow
accomplish
goal
ongo
surveil
healthcareassoci
infect
hcai
essenti
compon
hospit
infect
control
programm
goal
assess
burden
infecti
diseas
identifi
import
problem
monitor
efficaci
specif
intervent
support
ration
hospit
polici
nation
nosocomi
infect
surveil
system
establish
hcai
report
significantli
decreas
hospit
adopt
surveil
programm
hospitalwid
surveil
programm
highli
labour
intens
tend
divert
resourc
need
implement
control
measur
prevent
activ
consequ
often
minim
interest
hospit
policymak
except
major
outbreak
sever
acut
respiratori
syndrom
sar
becom
increasingli
appar
hospit
support
surveil
programm
need
justifi
improv
outcom
accomplish
goal
must
close
link
effect
intervent
strategi
first
infect
prevent
control
hospitalwid
hcai
surveil
programm
taiwan
base
intern
guidelin
establish
nation
taiwan
univers
hospit
ntuh
vigor
hospitalwid
hand
hygien
programm
initi
report
describ
secular
trend
hcai
ntuh
past
year
accord
site
infect
aetiolog
agent
control
measur
ntuh
teach
hospit
locat
taipei
taiwan
provid
primari
tertiari
medic
care
serv
approxim
inpati
outpati
emerg
depart
visit
daili
intens
care
unit
icu
bed
bed
acut
care
unit
bed
psychiatr
day
care
unit
among
acut
care
unit
follow
bed
medic
ward
surgic
ward
paediatr
ward
gynaecolog
ward
oncolog
ward
neg
pressur
isol
room
ntuh
infect
control
team
current
consist
fulltim
infect
control
nurs
icn
two
fulltim
technician
supervis
two
infect
diseas
physician
prospect
hospitalwid
onsit
surveil
hcai
conduct
weekli
visit
icn
patient
unit
hospit
chart
review
identifi
patient
hcai
accord
definit
center
diseas
control
prevent
help
infecti
diseas
physician
weekli
meet
data
collect
standardis
data
collect
form
appendix
incorpor
comput
databas
manual
entri
unitspecif
incid
hcai
episod
per
discharg
includ
overal
sitespecif
infect
rate
analys
monthli
compar
histor
data
feedback
provid
servic
stimul
intervent
measur
multipl
special
infect
prevent
control
event
intervent
occur
studi
period
prevent
control
measur
surgic
site
infect
ssi
includ
intensifi
surveil
ssi
feedback
surgeon
monitor
time
choic
prophylact
antibiot
reinforc
asept
procedur
amelior
monitor
ventil
oper
room
sinc
enhanc
environment
clean
organismspecif
isol
precaut
meticilllinresist
staphylococcu
aureu
mrsa
initi
augment
extens
drugresist
acinetobact
baumannii
xdrab
sarsspecif
precaut
march
june
infect
control
guidelin
xdrab
requir
contact
isol
singl
room
cohort
introduc
reinforc
follow
year
requir
icn
inform
staff
isol
patient
xdrab
hospitalwid
surveil
hcai
interrupt
temporarili
sar
epidem
icn
fulli
occupi
contain
sar
infect
prevent
control
programm
upgrad
implement
annual
intens
projectbas
control
programm
hospitalwid
hand
hygien
programm
institut
april
continu
annual
campaign
target
surveil
control
deviceassoci
infect
icu
eg
urinari
cathet
central
venou
cathet
ventil
ssi
select
surgic
procedur
initi
intensifi
sinc
data
analys
compar
nation
intern
data
feedback
everi
quarter
cultur
data
obtain
computergener
report
issu
hospit
clinic
microbiolog
laboratori
vitro
suscept
acinetobact
isol
determin
disc
diffus
method
follow
antibacteri
agent
test
cephalosporin
ceftazidim
cefepim
extendedspectrum
penicillin
piperacillintazobactam
carbapenem
imipenem
aminoglycosid
gentamicin
amikacin
fluoroquinolon
ciprofloxacin
sulbactam
colistin
vitro
suscept
test
colistin
begun
juli
xdrab
defin
baumannii
isol
resist
five
class
antibacteri
agent
poisson
regress
use
model
secular
trend
annual
incid
episod
per
discharg
hcai
poisson
regress
model
form
written
number
hcai
case
time
py
number
patientyear
discharg
time
b
repres
baselin
level
hcai
rate
hcai
rate
b
repres
annual
chang
hcai
time
indic
linear
trend
hcai
denot
time
year
estim
averag
annual
chang
calcul
b
neg
binomi
regress
appli
number
hcai
case
overdispers
ie
varianc
greater
mean
p
consid
signific
statist
analys
perform
use
sa
sa
institut
cari
nc
usa
annual
number
discharg
sever
underli
diseas
admiss
defin
charlson
comorbid
index
shown
figur
annual
infect
rate
increas
slowli
averag
per
year
rang
p
fluctuat
around
episod
per
discharg
figur
major
except
abrupt
increas
hcai
microbiolog
document
case
without
figur
attribut
intens
surveil
follow
adopt
center
diseas
control
cdc
atlanta
ga
usa
criteria
secular
trend
distribut
infect
accord
site
major
site
hcai
entir
studi
period
shown
figur
averag
annual
chang
confid
interv
bloodstream
infect
bsi
p
urinari
tract
infect
uti
p
respiratori
tract
infect
rti
p
ssi
p
differ
incid
proport
major
site
contribut
hcai
shown
tabl
ssi
lead
caus
hcai
peak
ssi
note
attribut
intens
surveil
without
postdischarg
surveil
pd
incid
ssi
decreas
sharpli
intensifi
infect
control
programm
bsi
gradual
increas
studi
period
rise
bsi
p
bsi
lead
hcai
site
account
hcai
incid
uti
increas
p
tabl
gramneg
bacteria
twice
common
gramposit
time
period
increas
fungal
infect
mainli
candida
spp
p
rate
c
difficil
infect
increas
episod
per
discharg
p
annual
percentag
chang
incid
pathogen
caus
hcai
shown
tabl
ii
averag
annual
increas
pathogenspecif
hcai
incid
mrsa
c
albican
xdrab
p
respect
incid
bsi
pathogen
increas
significantli
tabl
iii
secular
trend
pathogenspecif
bsi
rate
close
mirror
overal
rate
hcai
except
anaerob
secular
trend
major
pathogen
caus
bsi
shown
figur
fungi
mainli
candida
spp
rare
increas
rapidli
later
year
note
decreas
bsi
caus
aureu
acinetobact
spp
c
albican
escherichia
coli
implement
hand
hygien
programm
secular
trend
annual
incid
aureu
mrsa
shown
figur
secular
trend
annual
incid
acinetobact
xdrab
shown
figur
report
describ
secular
trend
hcai
cours
year
prospect
hospitalwid
surveil
programm
larg
univers
hospit
taiwan
major
find
similar
tertiari
care
hospit
western
countri
gradual
increas
admiss
patient
sever
underli
diseas
overal
rate
hcai
increas
slowli
fluctuat
approxim
episod
per
discharg
high
rang
report
tertiari
care
facil
time
trend
overal
infect
rate
tend
obscur
substanti
chang
ssi
rate
increas
bsi
increas
uti
appear
xdrab
mrsa
increas
fungal
infect
remark
decreas
ssi
may
result
improv
surgic
prophylaxi
activ
surveil
period
feedback
chang
surgic
practic
includ
increas
shift
day
surgeri
led
decreas
detect
ssi
system
depend
icn
go
inpati
chart
howev
pd
apart
patient
readmit
postop
complic
chang
hcai
may
due
multipl
factor
eg
implement
target
surveil
sar
outbreak
multidrugresist
organ
outbreak
activ
surveil
etc
rate
hcai
may
fluctuat
time
institut
sever
focus
control
programm
deal
increas
occurr
mrsa
xdrab
consist
intens
surveil
strict
isol
procedur
patient
xdrab
hand
hygien
programm
control
multidrugresist
organ
notabl
decreas
observ
overal
hcai
rate
sinc
hospitalwid
hand
hygien
programm
launch
howev
due
limit
postintervent
period
possibl
attribut
decreas
hand
hygien
programm
therefor
analysi
requir
expand
followup
period
might
make
formal
statist
infer
possibl
regard
pathogen
caus
healthcareassoci
bsi
multicentr
studi
usa
surveil
control
pathogen
epidemiolog
import
scope
show
gramposit
organ
account
case
lead
pathogen
coagulaseneg
staphylococci
aureu
enterococci
furthermor
proport
healthcareassoci
bsi
due
gramposit
cocci
increas
gradual
studi
show
coagulaseneg
staphylococci
lead
caus
healthcareassoci
bsi
howev
studi
gramneg
bacilli
account
healthcareassoci
bsi
lead
pathogen
klebsiella
spp
unusu
europ
north
america
therefor
consid
hcai
region
factor
consid
despit
achiev
yet
abl
achiev
goal
reduc
overal
infect
rate
may
imposs
reduc
rate
structur
immunocompromis
patient
popul
requir
aggress
antimicrobi
therapi
endogen
infect
third
patient
one
malign
hospit
also
maintain
activ
organ
bone
marrow
transplant
programm
icu
rate
infect
meaning
adjust
major
underli
diseas
diseas
sever
charlson
comorbid
index
mccabeejackson
criteria
acut
physiolog
assess
chronic
health
evalu
apach
score
appar
observ
need
major
shift
hospit
infect
prevent
control
measur
passiv
surveil
focus
control
programm
proven
efficaci
cdc
campaign
prevent
antimicrobi
resist
healthcar
set
provid
good
start
key
measur
optimis
condit
prevent
infect
eg
remov
unnecessari
devic
minimis
broad
spectrum
antibiot
avoid
long
term
antimicrobi
prophylaxi
treat
infect
rather
colonis
prevent
transmiss
major
success
achiev
adopt
measur
timetrend
analysi
perform
studi
consid
screen
tool
decid
whether
intens
investig
underli
caus
justifi
also
regress
analysi
allow
us
state
annual
chang
hcai
rate
howev
limit
studi
methodolog
viewpoint
studi
demonstr
chang
hcai
due
multipl
factor
occur
differ
time
period
thu
underli
trend
might
continu
increas
decreas
also
time
trend
might
overal
hcai
rate
sitespecif
pathogenspecif
hcai
rate
model
use
studi
quantifi
linear
trend
could
account
variat
possibl
serial
correl
howev
longer
time
period
one
year
use
analysi
minimis
correl
adjac
period
conclus
long
term
prospect
hospitalwid
surveil
studi
indic
need
address
prevent
control
hcai
need
shift
paradigm
surveil
feedback
implement
proven
control
measur
use
focus
surveil
monitor
efficaci
requir
greater
invest
part
hospit
want
reduc
hcai
minimum
thu
improv
qualiti
safeti
patient
care
